top of page

The Potential of GPT-4o in Social Prescribing for Isolated Patients and Polypharmacy Management

Expert Insight Series #3

The Potential of GPT-4o in Social Prescribing for Isolated Patients and Polypharmacy ManagementThe Potential of GPT-4o in Social Prescribing for Isolated Patients and Polypharmacy Management
The Potential of GPT-4o in Social Prescribing for Isolated Patients and Polypharmacy Management

Social prescribing, the practice of creating a personalised care plan based on what matters

to the patients which address social, emotional, and practical needs, has gained significant

traction as a holistic approach to healthcare delivery. For patients experiencing social

isolation and those grappling with the challenges of polypharmacy, the integration of GPT-

4o, an advanced language model, presents promising opportunities to enhance social

prescribing efforts while respecting its limitations in providing medical advice.


Addressing Social Isolation: A Multifaceted Approach


Social isolation can have profound and detrimental effects on both mental and physical

health, particularly among the elderly population and individuals living with chronic

conditions. In this context, GPT-4o can play a crucial role in identifying and supporting

socially isolated individuals through comprehensive social prescribing initiatives.


One key application of GPT-4o in this domain is its ability to be integrated into virtual

assistants or mobile applications, where it can provide personalized medication reminders.

This functionality can significantly promote medication adherence and reduce the risk of

adverse events associated with polypharmacy, without directly providing medical advice. By

serving as a reliable reminder system, GPT-4o can help ensure that patients take their

prescribed medications at the correct times and dosages, potentially improving treatment

outcomes and overall quality of life.


As wearable technology continues to advance, GPT-4o can also be leveraged to analyze

data from devices monitoring vital signs, such as heart rate, blood pressure, and oxygen

saturation levels. While the language model cannot interpret or diagnose medical conditions,

it can recognize potential deviations from normal ranges and promptly alert healthcare

providers or caregivers. This early warning system can facilitate timely interventions and

support from qualified medical professionals, potentially preventing or mitigating

exacerbations of underlying conditions.


Furthermore, by analyzing language patterns, speech, and behavioral data, GPT-4o can

potentially identify changes in communication abilities, such as declining verbal reasoning or

blank facial expressions. These subtle shifts can be indicative of underlying cognitive or

neurological issues, and their early detection can enable healthcare teams to provide

targeted interventions and support, ultimately improving patient outcomes and quality of life.


Beyond its technical capabilities, GPT-4o can also facilitate communication between

patients, family caregivers, and paid caregivers. By gathering valuable feedback and insights

from these various stakeholders, the language model can inform the development of


personalized care plans and social prescribing recommendations, without providing medical

advice directly.


Polypharmacy Management: A Collaborative Approach


Polypharmacy, the concurrent use of multiple medications, is an increasingly prevalent

concern, particularly among older adults and individuals with complex health conditions. In

this context, GPT-4o can contribute to polypharmacy management through social prescribing

initiatives, while deferring medical advice to qualified healthcare professionals.


One key application of GPT-4o in this domain is its ability to assist in medication

reconciliation. By integrating with electronic health records and patient-reported data, the

language model can identify potential discrepancies or duplications in medication regimens,

alerting healthcare providers for further evaluation and decision-making. This process can

help mitigate the risks associated with polypharmacy, such as adverse drug interactions,

medication errors, and non-adherence.


Additionally, GPT-4o can analyze patient data, including medical history, social determinants

of health, and personal preferences, to suggest personalized care plans that incorporate

social prescribing recommendations alongside traditional medical interventions. By taking a

holistic approach that considers both clinical and non-clinical factors, healthcare providers

can develop more comprehensive and tailored treatment strategies, potentially improving

patient outcomes and overall well-being.


Through its natural language processing capabilities, GPT-4o can also facilitate shared

decision-making by providing clear explanations of treatment options, potential risks, and

benefits. By empowering patients with accessible and easy-to-understand information, the

language model can support informed discussions between patients and their healthcare

providers, fostering a collaborative approach to care.


The "Neuro Timeline" & and Multidisciplinary Team Collaboration


One of the most promising applications of GPT-4o in social prescribing is the creation of a

Neuro Timeline a comprehensive record of a patient's activities, behaviors, and health

data. This timeline can be shared among multidisciplinary teams, including healthcare

providers, social workers, and community organizations, facilitating improved collaboration

and decision-making processes.


The Neuro Timeline can enhance shared decision-making by providing a holistic view of

the patients condition, ensuring that social prescribing recommendations align with the

patient's needs and preferences, as determined by healthcare professionals. With a

comprehensive understanding of the patient's journey, healthcare providers can tailor care plans more effectively, incorporating social prescribing interventions that address specific

social, emotional, and practical needs.


By optimizing care through social prescribing and multidisciplinary collaboration, the Neuro

Timeline can contribute to improved health outcomes and quality of life for patients.

Ultimately, this approach has the potential to enhance quality-adjusted life years (QALYs), a

metric that combines both the quantity and quality of life lived, highlighting the far-reaching

impact of this innovative approach.


Embracing Spatial Computing for Inclusive Social Prescribing


While GPT-4o presents exciting opportunities for social prescribing, it is crucial to address

the digital divide and ensure accessibility for patients with low digital literacy. Spatial

computing, which combines physical and digital environments, offers a promising solution to

bridge this gap.


Spatial computing technologies, such as augmented reality (AR) and mixed reality (MR), can

create immersive and intuitive interfaces that seamlessly blend the digital and physical

worlds. By integrating GPT-4o with spatial computing platforms, social prescribing initiatives

can become more inclusive and user-friendly, enabling patients with varying levels of digital

literacy to benefit from personalized care and support.


For instance, AR or MR applications could overlay digital information, such as medication

reminders or health data visualizations, onto the physical environment, providing a more

natural and intuitive interaction experience. Additionally, spatial computing interfaces could

leverage voice commands and gesture recognition, reducing the reliance on traditional input

methods that may be challenging for some patients.


As the healthcare landscape continues to evolve, embracing innovative technologies like

GPT-4o and spatial computing will be essential to delivering comprehensive, patient-

centered care through social prescribing initiatives. By leveraging these advancements,

healthcare providers can empower socially isolated patients, manage polypharmacy more

effectively, and ultimately improve health outcomes and quality of life, while respecting the

boundaries of GPT-4o's capabilities and deferring medical advice to qualified healthcare

professionals.

Arun Nadarasa

Written by: Arun Nadarasa





Arun Nadarasa is the CEO of the International Social Prescribing Pharmacy Association (ISPPA) and an Ambassador for the World Health Innovation Summit (WHIS). As a Cohort 8 member of the NHS Clinical Entrepreneur Program (CEP), he is championing Agentic Social Prescribing (ASP). With over a decade of combined experience spanning community, pharmaceutical, primary care, and NHS 111 settings, Arun is a qualified pharmacist driven by a passion for transforming healthcare delivery. His groundbreaking book, "Pharmacy Movement - How To Prescribe Social And Digital Medicines," is the first published work on the topic of Pharmacy Social Prescribing, cementing his role as a trailblazer in this emerging field.

16 views0 comments

Comments


bottom of page